Curi Bio
PrivateLast Round
Series B
Dec 2, 2025
Total Funding Raised
$24.4M
Company Overview
Curi Bio operates in Healthcare & Life Sciences and is based in Seattle, Washington. Its latest recorded funding round was a Series B round in December 2025.
Curi Bio is a biotechnology company that provides a preclinical discovery platform combining human stem cells, systems, and data to accelerate the discovery of new medicines.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Subscription SaaS, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curi Bio Comparables
Compare Curi Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MIMETAS | 87% | |
| CN Bio | 82% | |
| Emulate | 82% |
For institutional investors. Book with your work email.
Curi Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 2, 2025 | ||||
| Grant | Aug 23, 2023 | ||||
| Series A | Dec 29, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Curi Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dynamk Capital | Series A |
| UTC Investment | Series B, Series A |
| NIH RADx | Grant |
| DS Asset Management | Series B, Series A |
| National Center for Advancing Translational Sciences | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 23, 2026
Launched a commercially available HCM isogenic pair.
- Mar 20, 2026
Partnered with Battelle to commercialize NMJ assay technology.
For institutional investors. Book with your work email.
Curi Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Curi Bio's valuation, stock price, and market status.
Is Curi Bio a public or private company?
Curi Bio is a private company.
What is the current stock price of Curi Bio?
Curi Bio is a private company, so its shares have no public market price. Caplight tracks Curi Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Curi Bio worth (valuation)?
Valuation information for Curi Bio is not publicly available.
Can I buy Curi Bio stock?
Curi Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Curi Bio's last funding round?
Curi Bio's most recent funding round was Series B on December 2, 2025.
Who are the main investors in Curi Bio?
Key investors in Curi Bio include Dynamk Capital, NIH RADx.
Will Curi Bio IPO soon?
No public IPO plans have been announced for Curi Bio.
How can I track Curi Bio secondary market activity?
Caplight tracks bids, offers, and trades in Curi Bio's shares on secondary markets.